Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells

Endocrinology

Volumn 147, Issue 3, 2006, Pages 1203-1212

  Acconcia, Filippo ^a   Barnes, Christopher J ^a   Kumar, Rakesh ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TAMOXIFEN;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; GENOMICS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MOLECULAR RECOGNITION; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND HEALING;

ACTINS; ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; LIGANDS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TAMOXIFEN; TIME FACTORS; WOUND HEALING;

EID: 32644442664     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-1293     Document Type: Article

References (53)

1. Acconcia F, Kumar R 2 August 2005 Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 10.1016/j.canlet.2005. 06.018
2. Marino M, Pallottini V, Trentalance A 1998 Estrogens cause rapid activation of IP3-PKC-α signal transduction pathway in HEPG2 cells. Biochem Biophys Res Commun 245:254-258
3. Bjornstrom L, Sjoberg M 2002 Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16:2202-2214
4. Marino M, Acconcia F, Trentalance A 2003 Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAPkinase in HepG2 cells. Mol Biol Cell 14:2583-2591
5. Mazumdar A, Kumar R 2003 Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Lett 535:6-10
6. Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA, Xia P 2003 Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol 17:2002-2012
7. Mishra SK, Yang Z, Mazumdar A, Talukder AH, Larose L, Kumar R 2004 Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-γ2, an estrogen-responsive kinase. Oncogene 23:4422-4429
8. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M 2005 Survival versus apoptotic 17β-estradiol effect: role of ERα and ERβ activated non genomic signaling. J Cell Physiol 203:193-201
9. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
10. Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ 2002 Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol 16:116-127
11. Zhang Z, Kumar R, Santen RJ, Song RX 2004 The role of adapter protein Shc in estrogen non genomic action. Steroids 69:523-529
12. Albini A, Graf J, Kitten GT, Kleinman HK, Martin GR, Veillette A, Lippman ME 1986 17β-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane. Proc Natl Acad Sci USA 83:8182-8186
13. Fujimoto J, Hori M, Ichigo S, Morishita S, Tamaya T 1996 Estrogen activates migration potential of endometrial cancer cells through basement membrane. Tumour Biol 17:48-57
14. Fujimoto J, Hori M, Ichigo S, Morishita S, Tamaya T 1995 Estrogen activates invasiveness of endometrial cancel cells to the interstitium. Invasion Metastasis 15:135-143
15. Saji S, Kawakami M, Hayashi S, Yoshida N, Hirose M, Horiguchi S, Itoh A, Funata N, Schreiber SL, Yoshida M, Toi M 2005 Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene 24:4531-4539
16. Mitra SK, Hanson DA, Schlaepfer DD 2005 Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6:56-68
17. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC 2005 The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5:505-515
18. Zamir E, Geiger B 2001 Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci 114:3583-3590
19. Sapino A, Pietribiasi F, Bussolati G, Marchisio PC 1986 Estrogen- and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 cells. Cancer Res 46:2526-2531
20. DePasquale JA 1999 Rearrangement of the F-actin cytoskeleton in estradioltreated MCF-7 breast carcinoma cells. Histochem Cell Biol 112:341-350
21. DePasquale JA, Samsonoff WA, Gierthy JF 1994 17-β-Estradiol induced alterations of cell-matrix and intercellular adhesions in a human mammary carcinoma cell line. J Cell Sci 107:1241-1254
22. Geraldes P, Sirois MG, Bernatchez PN, Tanguay JF 2002 Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol 22:1585-1590
23. Savolainen-Peltonen H, Luoto NM, Kangas L, Hayry P 2004 Selective estrogen receptor modulators prevent neointima formation after vascular injury. Mol Cell Endocrinol 227:9-20
24. Ring A, Dowsett M 2004 Mechanisms of tamoxifen resistance. Endocr Relat Cancer 11:643-658
25. Smith CL, O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71
26. Howell SJ, Johnston SR, Howell A 2004 The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. Best Pract Res Clin Endocrinol Metab 18:47-66
27. Playford MP, Schaller MD 2004 The interplay between Src and integrins in normal and tumor biology. Oncogene 23:7928-7946
28. Sells MA, Pfaff A, Chernoff, J 2002 Temporal and spatial distribution of activated Pak1 in fibroblasts. J Cell Biol 151:1449-1458
29. Castro-Rivera E, Safe S 1998 Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture. J Steroid Biochem Mol Biol 64:287-295
30. Jones PS, Parrott E, White IN 1999 Activation of transcription by estrogen receptor α and β is cell type-and promoter-dependent. J Biol Chem 274:32008-32014
31. Treeck O, Diedrich K, Ortmann O 2003 The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrialadenocarcinoma cell lines. Eur J Cancer 39:1302-1309
32. Leong H, Riby JE, Firestone GL, Bjeldanes LF 2004 Potent ligand-independent estrogen receptor activation by 3,3′-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways. Mol Endocrinol 18:291-302
33. Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller Jr WH 2004 ERβ sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk. Mol Cancer Res 2:523-531
34. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707
35. Lannigan DA 2003 Estrogen receptor phosphorylation. Steroids 68:1-9
36. Laios I, Journe F, Nonclercq D, Vidal DS, Toillon RA, Laurent G, Leclercq G 2005 Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells. J Steroid Biochem Mol Biol 94:347-359
37. 1 gene transcription in HepG2 cells. Mol Biol Cell 13:3720-3729
38. Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, ameson JL 2002 An estrogen receptor (ER) α deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 16:2188-2201
39. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, and Marino M 2005 Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Mol Biol Cell 16:231-237
40. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER 2002 ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115
41. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER 2004 Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18:2854-2865
42. Yang Z, Barnes CJ, Kumar R 2004 Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor α in breast cancer cells. Clin Cancer Res 10:3621-3628
43. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ 2004 The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc Natl Acad Sci USA 101:2076-2081
44. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH 2004 Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. Proc Natl Acad Sci USA 101:17126-17131
45. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630
46. Pappas TC, Gametchu B, Watson CS 1995 Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9:404-410
47. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319
48. Chambliss KL, Simon L, Yuhanna YI, Mineo C, Shaul PW 2005 Dissecting the basis of nongenomic activation of eNOS by estradiol: role of ERα domains with known nuclear functions. Mol Endocrinol 19:277-289
49. McNamara DA, Harmey J, Wang JH, Kay E, Walsh TN, Bouchier-Hayes DJ 2001 Tamoxifen inhibits endothelial cell proliferation and attenuates VEGFmediated angiogenesis and migration in vivo. Eur J Surg Oncol 27:714-718
50. Chen J, Thompson LU 2003 Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 80:163-170
51. Hoelting T, Siperstein AE, Duh QY, Clark OH 1995 Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo. J Clin Endocrinol Metab 80:308-313
52. 1-integrin fibronectin receptors in human endometrial stromal cells and carcinoma cells. Pathobiology 65:177-183
53. Balda MS, Matter K 2003 Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol 13:310-318